Enhanced stability and potency of novel growth hormone-releasing factor (GRF) analogues derived from rodent and human GRF sequences
- 31 December 1994
- Vol. 15 (3) , 489-495
- https://doi.org/10.1016/0196-9781(94)90211-9
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Proteolytic degradation of rat growth hormone-releasing factor(1–29) amide in rat pituitary and hypothalamusBrain Research, 1993
- Synthesis and biological activity of novel C-terminal-extended and biotinylated growth hormone-releasing factor (GRF) analogsPeptides, 1992
- Catabolism of rat growth hormone-releasing factor(1–29) amide in rat serum and liverPeptides, 1992
- Kinetics of dipeptidyl peptidase IV proteolysis of growth hormone-releasing factor and analogsBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1992
- Degradation of aspartic acid and asparagine residues in human growth hormone‐releasing factorInternational Journal of Peptide and Protein Research, 1992
- Human growth hormone-releasing hormone analogues with much improved in vitro growth hormone-releasing potencies in rat pituitary cellsEuropean Journal of Pharmacology, 1991
- Expression of growth hormone-releasing factor analog Leu27GRF(1–44)OH in Escherichia coli: Purification and characterization of the expressed proteinArchives of Biochemistry and Biophysics, 1991
- GRF analogs and fragments: Correlation between receptor binding, activity and structurePeptides, 1991
- Degradation of growth hormone releasing factor analogs in neutral aqueous solution is related to deamidation of asparagine residuesInternational Journal of Peptide and Protein Research, 1991
- Rapid enzymatic degradation of growth hormone-releasing hormone by plasma in vitro and in vivo to a biologically inactive product cleaved at the NH2 terminus.Journal of Clinical Investigation, 1986